Table 2.
Mechanism | Interpretation | Ref | |
---|---|---|---|
Indirect Neurotoxicity | Induction of oxidative Stress | Excess ROS production leads to the oxidative modification of biochemical molecules such as proteins, lipids, and nucleic acids. | Birben E et al. (72) |
ROS can activate NF-κB. | Herb M et al. (73) | ||
Yan S et al. (74) | |||
Inflammation | TNF-α can affect the volume of the hippocampus. | Kwatra M et al. (39) | |
TNF-α can inhibit the long-term enhancing effects of hippocampal CA1 and the dentate gyrus. | Motaghinejad M et al. (75) | ||
TNF-α can augment the inflammatory signals by activating astrocytes and microglia, which lead to the local production of TNF-α in the brain. | Guidotti G et al. (76) | ||
Zhou H et al. (77) | |||
Binding of TNF-α to TNFR recruits intracellular proteins and transduces inflammatory signaling, leading to NF-κB translocates to the nucleus. | Mohamed RH et al. (78) | ||
Wu YQ et al. (79) | |||
activation of microglia and astrocytes via TNFR1 can enhance the expression and activity of NOX, particularly NOX2, leading to an increase in ROS production. | Blaser H et al. (80) | ||
Indirect Neurotoxicity | Nitrification Stress | the nitrated MnSOD resulted in impaired mitochondrial respiratory activity, which in turn synergized with O2•− production. | Tangpong J et al. (30) |
Holley et al. (81) | |||
Apolipoprotein A-I | ApoA-1 exerts anti-inflammatory effects by blocking contact between activated T lymphocytes and monocytes and inhibiting the production of TNF-α. | Ronkina N et al. (82) | |
ApoA-1 is sensitive to the doxorubicin-induced oxidative damage, leading to dyslipidemia and increased circulating TNF-α. | Ramalingayya GV et al. (22) | ||
Aluise CD et al. (70) | |||
Tangpong J et al. (83) |
NF-κB, nuclear factor-κB; TNFR, TNF-α receptor; TNFR1, TNF-α receptor 1; NOX, NADPH oxidases; MnSOD:manganese superoxide dismutase; ApoA-1, Apolipoprotein A-I.